US78081BAH69 · USD

Royalty Pharma Plc 1.20% 2025/09

MID PRICE
par = 100
YIELD TO MAT.
semi-annual
COUPON
1.200%
semi-annual · fixed
MATURITY
2025-09-02
matured
OUTSTANDING
not disclosed
AS OF

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

About this bond

AI BRIEF · GROUNDED IN STRUCTURED DATA
About the issuer

Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.

Source: Wikipedia →

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100

Bond has reached or passed its maturity date — duration analytics no longer apply.

Price history

No price history yet. Daily ingestion will accumulate history as new snapshots arrive.

Sherpa Signal

AS OF 2025-08-31

Institutional footprint · signal-level holdings

47/ 100Active coverage
Interpretation. Light institutional footprint, holding
HOLDERS
13
signals holding
AGGREGATE EXPOSURE
$37.7M
USD across all
TOP CONCENTRATION
51.1%
largest holder
FLOW
awaiting history

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
No price available yet

RFQ routing · coming soon

Security details

AWAITING ENRICHMENT
CUSIP
78081BAH6
ISIN
US78081BAH69
Face value
100 USD
Seniority
Senior Unsecured

Issuer curve

Royalty · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.